What is the equity of BioCorRx this year?
BioCorRx has equity of -9.82 M USD this year.
BioCorRx Equity 2024
BioCorRx Equity
-9.82 M USD
Ticker
BICX
ISIN
US09073C2052
WKN
A1XERB
In 2024, BioCorRx's equity was -9.82 M USD, a 21.58% increase from the -8.08 M USD equity in the previous year.
BioCorRx Aktienanalyse
What does BioCorRx do?
The company BioCorRx Inc is a US-American company that was founded in 2008 and is headquartered in Anaheim, California. BioCorRx specializes in the development and marketing of innovative treatment methods for alcohol and drug dependency. The history of BioCorRx began with the introduction of its flagship product, the BioCorRx Recovery Program, which is based on a novel medical technology called Naltrexone/Buprenorphine Implant. Unlike traditional methods of treating alcohol and drug addiction, which typically rely on medication and psychotherapeutic support, the BioCorRx Recovery Program is an implantable, long-term treatment system that continuously delivers the active ingredient Naltrexone or Buprenorphine into the patient's body. The idea behind this is that the active ingredients prevent withdrawal symptoms and thereby reduce the risk of relapse. In recent years, BioCorRx has expanded its product portfolio and expanded its business activities to new segments in order to further drive the company's growth. This includes, for example, the field of telemedicine services, which allow BioCorRx to offer its treatment technology and medical services through online communication. Telemedicine services such as virtual patient consultation or online group therapy programs are particularly in demand in times of COVID-19. Another focus of BioCorRx is the management of medical personnel. Studies have shown that good patient care and counseling heavily influence the success of treatment. BioCorRx has now also developed its own platform that eases and improves the management, training, and monitoring of medical staff. BioCorRx also utilizes the concept of franchise systems to market its products and services. The franchise system offers medical professionals and organizations working in the field of addiction treatment the opportunity to open their own BioCorRx clinic and offer the company's products and services in their local market. Each clinic is advised and supported by BioCorRx and must adhere to certain standards and quality criteria. In the future, BioCorRx plans to further diversify its product offering and develop new technologies to improve treatment options for alcohol and drug dependents. An example of such a technology is medication based on Ibogaine. BioCorRx has already started initial research in this direction and is actively working on pre-clinical studies. Overall, BioCorRx is a company that primarily focuses on innovative technologies for the treatment of addiction. The company has experienced substantial growth in recent years by expanding its product range and customer base, and focusing on the areas of telemedicine, personnel management, and franchise systems. With its forward-thinking technologies and strong emphasis on quality and patient satisfaction, BioCorRx is expected to continue playing an important role in addiction treatment in the years to come. BioCorRx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing BioCorRx's Equity
BioCorRx's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BioCorRx's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating BioCorRx's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
BioCorRx's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in BioCorRx’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about BioCorRx stock
What was the equity of BioCorRx compared to the previous year?
The equity of BioCorRx has increased/decreased by 21.58% increased compared to the previous year.
What impact does a high equity have on investors of BioCorRx?
A high equity is advantageous for investors of BioCorRx as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of BioCorRx?
A low equity can be a risk for investors of BioCorRx, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of BioCorRx affect the company?
An increase in equity of BioCorRx can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of BioCorRx affect the company?
A reduction in equity of BioCorRx can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of BioCorRx?
Some factors that can affect the equity of BioCorRx include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of BioCorRx so important for investors?
The equity of BioCorRx is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can BioCorRx take to change the equity?
To change equity, BioCorRx can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does BioCorRx pay?
Over the past 12 months, BioCorRx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioCorRx is expected to pay a dividend of 0 USD.
What is the dividend yield of BioCorRx?
The current dividend yield of BioCorRx is .
When does BioCorRx pay dividends?
BioCorRx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioCorRx?
BioCorRx paid dividends every year for the past 0 years.
What is the dividend of BioCorRx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioCorRx located?
BioCorRx is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioCorRx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioCorRx from 11/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/4/2024.
When did BioCorRx pay the last dividend?
The last dividend was paid out on 11/4/2024.
What was the dividend of BioCorRx in the year 2023?
In the year 2023, BioCorRx distributed 0 USD as dividends.
In which currency does BioCorRx pay out the dividend?
The dividends of BioCorRx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioCorRx
Our stock analysis for BioCorRx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioCorRx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
